Quadra Logic Technologies Inc. regulatory update

Quadra Logic Technologies Inc. (QLTIF) QLTIF's light activated drug, Photofrin, received marketing approval in Japan to treat early-stage lung cancer, superficial esophageal cancer, superficial and e...